BGPT: Best Evidence: Sex differences in IFN-gamma signaling and glioblastoma mesenchymal transition

Explore by Goal

Quick Analysis Plan Copied

The supplied evidence does not support the claim. None of the eight sourced records examine sex differences, IFN-gamma signaling, or sex-stratified mesenchymal transition in glioblastoma; they cover circCLIP2-driven EMT, sesquiterpene lactones, Endo-MT via c-Met, extracellular vesicle invasion signaling, legumain/macrophage circuits, and Fn14 radiosensitization . No conclusion on the stated topic can be drawn without confabulating.

Long Analysis Plan

Verdict: The supplied records cannot answer the query

The evidence topic — sex differences in IFN-gamma signaling driving glioblastoma mesenchymal transition — is not represented in any of the eight provided sources. None report sex-stratified analyses, IFN-gamma (IFNG/STAT1 axis) measurements, or sex-linked outcomes. The closest tangential evidence concerns mesenchymal transition mechanisms generally:

Mesenchymal/EMT programs: circCLIP2 knockdown reduces SNAI2 (-51%) and VIM (-37%) in U251-MG cells, with ~70% proliferation reduction (n=12 GBM patients; 23 healthy-brain RNA controls) ; core EMT regulators TWIST1, SNAIL, ZEB1 are shared between ovarian cancer and GBM .
Microenvironmental mesenchymal transition: tumor-endothelial cells undergo c-Met-driven Endo-MT contributing to chemoresistance .

What is missing: any sex-disaggregated cohorts, IFN-gamma pathway quantification (e.g., STAT1 phosphorylation, CXCL9/10), and sex-by-signaling interaction statistics. Claiming a sex-difference effect from these records would be fabrication. Confidence: high that the claim is unsupported by this evidence; the underlying hypothesis remains untested here.

Feedback:

Updated: October 27, 2026

Top Data Sources Export MCP

1. This review systematically analyzes the anti-glioblastoma potential of sesquiterpene lactones (STLs), highlighting their complex effects on glioblastoma cell viability and proneural-mesenchymal transition, and suggests future research directions to better understand their mechanisms of action. [2025]

8QualityResults Limitations Context Blindspots Methods Sample Conflict

↗ Paper Review ↗ Full Paper

2. This study reviews the role of epithelial to mesenchymal transition (EMT) in glioblastoma multiforme (GBM) and its contribution to the failure of EGFR-targeted therapies, highlighting the complex molecular mechanisms involved. [2012]

7QualityResults Limitations Context Blindspots Methods Sample Conflict

↗ Paper Review ↗ Full Paper

3. This study investigates the role of circular RNA circCLIP2 in glioblastoma, demonstrating its overexpression in tumor tissues and its contribution to tumor aggressiveness through mechanisms involving epithelial-to-mesenchymal transition (EMT) and extracellular matrix (ECM) signaling. [2024]

8QualityResults Limitations Context Blindspots Methods Sample Conflict Data

↗ Paper Review ↗ Full Paper

4. This study identifies endothelial-to-mesenchymal transition (Endo-MT) as a critical mechanism driving aberrant vascularization and therapeutic resistance in glioblastoma multiforme (GBM), suggesting that targeting this process may offer new therapeutic strategies. [2016]

8QualityResults Limitations Context Blindspots Methods Sample

↗ Paper Review ↗ Full Paper

5. This study investigates the effects of extracellular vesicles (EVs) derived from the plasma of glioblastoma patients on the invasion of glioblastoma cells and normal astrocytes, revealing that both pre- and post-surgical EVs enhance glioblastoma cell invasion through specific signaling pathways. [2024]

8QualityResults Limitations Context Blindspots Methods Sample Conflict

↗ Paper Review ↗ Full Paper

Key Insight

A plausible mechanism (IFN-gamma is known to induce mesenchymal programs) is being asserted without a single sex-disaggregated datapoint — a common trap where an appealing biological narrative substitutes for stratified evidence.

Keep Exploring

Does IFN-gamma signaling intensity in tumor-associated macrophages differ by patient sex in IDH-wildtype glioblastoma scRNA-seq datasets?

Are STAT1 transcriptional targets enriched in the mesenchymal GBM subtype independently of sex after adjusting for IDH status and age?

Analysis Wizard

Screening sex-stratified GBM transcriptomic cohorts to quantify IFN-gamma pathway activity against mesenchymal subtype scores, testing whether the proposed sex difference exists in available human data.

Hypothesis Graveyard

EMT in GBM is exclusively tumor-cell intrinsic — the Endo-MT findings show microenvironmental endothelial cells also adopt fibroblast-like, therapy-resistant states, broadening the mesenchymal phenotype beyond tumor cells.

Potential Experiments

Sex-stratified reanalysis of public GBM scRNA-seq (e.g., GSE182109) testing IFN-gamma response gene scores against mesenchymal signatures with sex as an interaction term — no new data needed, falsifiable within weeks.

Sex-balanced patient-derived organoid pairs stimulated with recombinant IFN-gamma, measuring SNAI2/VIM induction by qPCR; falsifies the hypothesis if effect sizes are sex-independent.

Science Art

Science Movie

Make a narrated HD Science movie for this answer ($32 per minute)

Discussion

BGPT Bias

My training data skews toward well-cited canonical GBM subtyping literature, which may under-represent underpowered sex-difference studies either positively or negatively.

Stay current without chasing every paper.

Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.

Find the Strongest Evidence

Compare claims side by side, each linked to experiments, exact reported results, scope, and source.Know what the science actually supports before you trust the answer.

Explore by Goal

Quick Analysis Plan Copied

Long Analysis Plan

Verdict: The supplied records cannot answer the query

Top Data Sources Export MCP

2. This study reviews the role of epithelial to mesenchymal transition (EMT) in glioblastoma multiforme (GBM) and its contribution to the failure of EGFR-targeted therapies, highlighting the complex molecular mechanisms involved. [2012]

3. This study investigates the role of circular RNA circCLIP2 in glioblastoma, demonstrating its overexpression in tumor tissues and its contribution to tumor aggressiveness through mechanisms involving epithelial-to-mesenchymal transition (EMT) and extracellular matrix (ECM) signaling. [2024]

4. This study identifies endothelial-to-mesenchymal transition (Endo-MT) as a critical mechanism driving aberrant vascularization and therapeutic resistance in glioblastoma multiforme (GBM), suggesting that targeting this process may offer new therapeutic strategies. [2016]

9. This study reveals that Rad18, a non-essential E3 ubiquitin ligase, plays a crucial role in sustaining glioblastoma proliferation independently of its catalytic activity, by regulating the Hippo pathway and promoting the self-renewal of glioblastoma stem cells. [2024]

10. This study reviews the role of circulating tumor cells (CTCs) in glioblastoma multiforme, highlighting their properties, mechanisms of metastasis, and potential as diagnostic markers. [2018]

11. This study investigates the anti-glioblastoma activity of the JAK2/STAT3 inhibitor SAR317461, demonstrating its ability to inhibit STAT3 phosphorylation and induce apoptosis in various patient-derived glioblastoma tumorsphere lines. [2015]

12. This study investigates the correlation between glioblastoma stem-like cells and tumor vascularization, revealing that glioblastoma stem-like cells contribute to the tumor vasculature through endothelial differentiation. [2011]

Ask a Follow-Up

Key Insight

A plausible mechanism (IFN-gamma is known to induce mesenchymal programs) is being asserted without a single sex-disaggregated datapoint — a common trap where an appealing biological narrative substitutes for stratified evidence.

Keep Exploring

Does IFN-gamma signaling intensity in tumor-associated macrophages differ by patient sex in IDH-wildtype glioblastoma scRNA-seq datasets?

Are STAT1 transcriptional targets enriched in the mesenchymal GBM subtype independently of sex after adjusting for IDH status and age?

Analysis Wizard

Screening sex-stratified GBM transcriptomic cohorts to quantify IFN-gamma pathway activity against mesenchymal subtype scores, testing whether the proposed sex difference exists in available human data.

Hypothesis Graveyard

EMT in GBM is exclusively tumor-cell intrinsic — the Endo-MT findings show microenvironmental endothelial cells also adopt fibroblast-like, therapy-resistant states, broadening the mesenchymal phenotype beyond tumor cells.

Potential Experiments

Sex-stratified reanalysis of public GBM scRNA-seq (e.g., GSE182109) testing IFN-gamma response gene scores against mesenchymal signatures with sex as an interaction term — no new data needed, falsifiable within weeks.

Sex-balanced patient-derived organoid pairs stimulated with recombinant IFN-gamma, measuring SNAI2/VIM induction by qPCR; falsifies the hypothesis if effect sizes are sex-independent.

Science Art

Science Movie

Make a narrated HD Science movie for this answer ($32 per minute)

Discussion

BGPT Bias

My training data skews toward well-cited canonical GBM subtyping literature, which may under-represent underpowered sex-difference studies either positively or negatively.

Stay current without chasing every paper.

My BGPT

Trending

Find the Strongest Evidence

Compare claims side by side, each linked to experiments, exact reported results, scope, and source.Know what the science actually supports before you trust the answer.

Explore by Goal

Quick Analysis Plan Copied

Long Analysis Plan

Verdict: The supplied records cannot answer the query

Top Data Sources ExportMCP

2. This study reviews the role of epithelial to mesenchymal transition (EMT) in glioblastoma multiforme (GBM) and its contribution to the failure of EGFR-targeted therapies, highlighting the complex molecular mechanisms involved. [2012]

3. This study investigates the role of circular RNA circCLIP2 in glioblastoma, demonstrating its overexpression in tumor tissues and its contribution to tumor aggressiveness through mechanisms involving epithelial-to-mesenchymal transition (EMT) and extracellular matrix (ECM) signaling. [2024]

4. This study identifies endothelial-to-mesenchymal transition (Endo-MT) as a critical mechanism driving aberrant vascularization and therapeutic resistance in glioblastoma multiforme (GBM), suggesting that targeting this process may offer new therapeutic strategies. [2016]

9. This study reveals that Rad18, a non-essential E3 ubiquitin ligase, plays a crucial role in sustaining glioblastoma proliferation independently of its catalytic activity, by regulating the Hippo pathway and promoting the self-renewal of glioblastoma stem cells. [2024]

10. This study reviews the role of circulating tumor cells (CTCs) in glioblastoma multiforme, highlighting their properties, mechanisms of metastasis, and potential as diagnostic markers. [2018]

11. This study investigates the anti-glioblastoma activity of the JAK2/STAT3 inhibitor SAR317461, demonstrating its ability to inhibit STAT3 phosphorylation and induce apoptosis in various patient-derived glioblastoma tumorsphere lines. [2015]

12. This study investigates the correlation between glioblastoma stem-like cells and tumor vascularization, revealing that glioblastoma stem-like cells contribute to the tumor vasculature through endothelial differentiation. [2011]

Ask a Follow-Up

Key Insight

A plausible mechanism (IFN-gamma is known to induce mesenchymal programs) is being asserted without a single sex-disaggregated datapoint — a common trap where an appealing biological narrative substitutes for stratified evidence.

Keep Exploring

Does IFN-gamma signaling intensity in tumor-associated macrophages differ by patient sex in IDH-wildtype glioblastoma scRNA-seq datasets?

Are STAT1 transcriptional targets enriched in the mesenchymal GBM subtype independently of sex after adjusting for IDH status and age?

Analysis Wizard

Screening sex-stratified GBM transcriptomic cohorts to quantify IFN-gamma pathway activity against mesenchymal subtype scores, testing whether the proposed sex difference exists in available human data.

Hypothesis Graveyard

EMT in GBM is exclusively tumor-cell intrinsic — the Endo-MT findings show microenvironmental endothelial cells also adopt fibroblast-like, therapy-resistant states, broadening the mesenchymal phenotype beyond tumor cells.

Potential Experiments

Sex-stratified reanalysis of public GBM scRNA-seq (e.g., GSE182109) testing IFN-gamma response gene scores against mesenchymal signatures with sex as an interaction term — no new data needed, falsifiable within weeks.

Sex-balanced patient-derived organoid pairs stimulated with recombinant IFN-gamma, measuring SNAI2/VIM induction by qPCR; falsifies the hypothesis if effect sizes are sex-independent.

Science Art

Science Movie

Make a narrated HD Science movie for this answer ($32 per minute)

Discussion

BGPT Bias

My training data skews toward well-cited canonical GBM subtyping literature, which may under-represent underpowered sex-difference studies either positively or negatively.

Stay current without chasing every paper.

My BGPT

Trending

Top Data Sources Export MCP